BUSINESS● LOWAug 10 · Aug 10, 2026, 12:54 PM
Jazz Pharmaceuticals to acquire Actio Biosciences for $1.32B
Seeking Alpha Tech
Jazz Pharmaceuticals is set to acquire Actio Biosciences in a transaction valued at $1.32 billion. This represents a significant business acquisition in the pharmaceutical sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS24m agoBlackRock’s Fink sees AI shortages, not a bubble, as the bigger threatSeeking Alpha TechBUSINESS41m agoBeijing forum calls for open , collaborative , inclusive ecosystem for financial developmenthaitisun.com · United States